AdaptHealth Corp. (NASDAQ:AHCO) Shares Sold by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. lowered its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 59.4% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 205,590 shares of the company's stock after selling 301,092 shares during the period. D. E. Shaw & Co. Inc. owned approximately 0.15% of AdaptHealth worth $1,957,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in AHCO. Assetmark Inc. purchased a new position in shares of AdaptHealth during the 4th quarter worth approximately $28,000. Blue Trust Inc. boosted its position in shares of AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after purchasing an additional 1,115 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in shares of AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock worth $121,000 after purchasing an additional 1,690 shares during the period. Guggenheim Capital LLC boosted its position in shares of AdaptHealth by 10.1% during the 4th quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after purchasing an additional 1,525 shares during the period. Finally, KLP Kapitalforvaltning AS acquired a new stake in AdaptHealth during the 4th quarter worth approximately $169,000. Hedge funds and other institutional investors own 82.67% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on AHCO shares. Royal Bank of Canada reduced their target price on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a report on Thursday, May 8th. UBS Group reduced their target price on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a report on Thursday, February 13th. Canaccord Genuity Group increased their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Robert W. Baird increased their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. Finally, Truist Financial reduced their target price on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, May 12th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Stock Up 1.8%

Shares of AHCO traded up $0.16 during midday trading on Tuesday, reaching $8.94. The stock had a trading volume of 34,549 shares, compared to its average volume of 1,280,785. AdaptHealth Corp. has a 1-year low of $7.11 and a 1-year high of $11.90. The company's fifty day simple moving average is $9.05 and its two-hundred day simple moving average is $9.63. The company has a market cap of $1.21 billion, a price-to-earnings ratio of -5.41, a PEG ratio of 1.08 and a beta of 1.64. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.